CRP and COVID-19: Furthermore, in a randomized controlled trial of severely hospitalized patients with COVID-19, quercetin, in combination with remdesivir and favipiravir, was associated with earlier hospital discharge and decreased serum levels of alkaline phosphatase (ALP), q-C-reactive protein (q–CRP), and lactate dehydrogenase (LDH), which are all inflammatory markers related to the disease course of COVID-19 [198], thus marking an association with improved disease outcomes.